Dr. Staskin assesses vibegron outcomes for patients with OAB dry

“Vibegron for the treatment of patients with dry overactive bladder: A subgroup analysis from the EMPOWUR trial,” presented at the 2021 American Urological Association annual meeting. Staskin is a director of the Center for Male and Female Pelvic Health and associate professor of urology at Tufts University, Boston, Massachusetts.

Related Videos
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Patient predictors of postprostatectomy incontinence | Image credit: © jakkapan - stock.adobe.com
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Dr. Woodburn in an interview with Urology Times
Dean Elterman, MD, MSc, FRCSC, in an interview with Urology Times
Anjali Kapur, MD, looks at the camera while answering a question
Anjali Kapur, MD, answers a question about a recent study regarding third-line treatments for OAB
jakkapan - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.